MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
45.57
+1.30
+2.94%
After Hours: 45.57 0 0.00% 16:05 05/12 EDT
OPEN
45.09
PREV CLOSE
44.27
HIGH
46.23
LOW
44.80
VOLUME
385.95K
TURNOVER
--
52 WEEK HIGH
54.23
52 WEEK LOW
23.83
MARKET CAP
2.26B
P/E (TTM)
-28.2360
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Bio-Techne (TECH), Mirum Pharmaceuticals (MIRM)
TipRanks · 12h ago
Weekly Report: what happened at MIRM last week (0505-0509)?
Weekly Report · 14h ago
Analysts Conflicted on These Healthcare Names: Regulus (RGLS), Mirum Pharmaceuticals (MIRM) and Kymera Therapeutics (KYMR)
TipRanks · 15h ago
Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
TipRanks · 15h ago
Mirum’s volixibat shows ‘best-in-class potential,’ says Citi
TipRanks · 15h ago
MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 3d ago
Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock
Benzinga · 3d ago
Mirum Pharmaceuticals Is Maintained at Market Outperform by JMP Securities
Dow Jones · 3d ago
More
About MIRM
More
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Recently
Symbol
Price
%Change

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.